SPYGLASS | A Disruptive AntimicrobialSmart Photocatalytic Glass: A Disruptive Antimicrobial Coating for the Protection of Glass Surfaces & Designed to Tackle the Emergent Crisis of Resistant Microbes and Viruses

Summary
Kastus® is an Award-Winning surface innovation company founded in 2014 with global headquarters and manufacturing based in Ireland. Our patented range of antimicrobial (AM) and hydrophilic coatings are designed to enhance surfaces across our 2 core Industries, Glass (TRL 8) and Ceramics. In relation to the antimicrobial coatings, the technology is designed to eliminate up to 99.99% of harmful bacteria and viruses such as Corona, C. Diff, MRSA and E. Coli. Kastus® has also been funded by Atlantic Bridge (VC) to get the technology from TRL 3 to 8 and funding is now required to get to get the glass formulation to TRL 9. Kastus® needs the EIC support to accelerate the technology into full production and allow us to expand our disruptive technology offering into the entire touchscreen and glass AM sectors. We have built the momentum and the funding and support from the EIC will enable us to expand and build a global European company with forecasted revenues in 2025 of over €42m. Without the funding, the risk of losing first to market advantage is high due to the large cost needed to commercialise. Previous submission to SME Instrument in July 2019, Kastus® was awarded the Seal of Excellence.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/959211
Start date: 01-08-2020
End date: 31-07-2022
Total budget - Public funding: 2 873 511,00 Euro - 1 609 166,00 Euro
Cordis data

Original description

Kastus® is an Award-Winning surface innovation company founded in 2014 with global headquarters and manufacturing based in Ireland. Our patented range of antimicrobial (AM) and hydrophilic coatings are designed to enhance surfaces across our 2 core Industries, Glass (TRL 8) and Ceramics. In relation to the antimicrobial coatings, the technology is designed to eliminate up to 99.99% of harmful bacteria and viruses such as Corona, C. Diff, MRSA and E. Coli. Kastus® has also been funded by Atlantic Bridge (VC) to get the technology from TRL 3 to 8 and funding is now required to get to get the glass formulation to TRL 9. Kastus® needs the EIC support to accelerate the technology into full production and allow us to expand our disruptive technology offering into the entire touchscreen and glass AM sectors. We have built the momentum and the funding and support from the EIC will enable us to expand and build a global European company with forecasted revenues in 2025 of over €42m. Without the funding, the risk of losing first to market advantage is high due to the large cost needed to commercialise. Previous submission to SME Instrument in July 2019, Kastus® was awarded the Seal of Excellence.

Status

CLOSED

Call topic

EIC-SMEInst-2018-2020

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.0. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-EIC-SMEInst-2018-2020-3
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.0. INDUSTRIAL LEADERSHIP - Innovation In SMEs - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-EIC-SMEInst-2018-2020-3
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.0. Cross-cutting call topics
H2020-EIC-SMEInst-2018-2020
H2020-EIC-SMEInst-2018-2020-3